These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 7015133)
1. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. Weiden PL; Sullivan KM; Flournoy N; Storb R; Thomas ED; N Engl J Med; 1981 Jun; 304(25):1529-33. PubMed ID: 7015133 [No Abstract] [Full Text] [Related]
2. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. Weiden PL; Flournoy N; Thomas ED; Prentice R; Fefer A; Buckner CD; Storb R N Engl J Med; 1979 May; 300(19):1068-73. PubMed ID: 34792 [TBL] [Abstract][Full Text] [Related]
3. The status of bone marrow transplantation for leukemia. McGlave PB Hosp Pract (Off Ed); 1985 Nov; 20(11):97-110. PubMed ID: 2997246 [No Abstract] [Full Text] [Related]
4. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937 [TBL] [Abstract][Full Text] [Related]
5. Leukemia relapse after allogeneic bone marrow transplantation: how does chronic graft-versus-host disease influence the pattern and onset of relapse? Al Beihany A; Al Mohareb F; Al Zahrani H; Alsharif F; Chaudhri N; Mohamed SY; Rasheed W; Aljurf M Exp Clin Transplant; 2011 Dec; 9(6):432-3. PubMed ID: 22142055 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation in leukemia. Kolb HJ Recent Results Cancer Res; 1984; 93():269-89. PubMed ID: 6382484 [No Abstract] [Full Text] [Related]
7. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia. Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947 [TBL] [Abstract][Full Text] [Related]
8. Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. Weiden PL; Flournoy N; Sanders JE; Sullivan KM; Thomas ED Transplant Proc; 1981 Mar; 13(1 Pt 1):248-51. PubMed ID: 7022833 [No Abstract] [Full Text] [Related]
9. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies. Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S Clin Transpl; 1996; ():281-90. PubMed ID: 9286578 [TBL] [Abstract][Full Text] [Related]
11. Allogeneic marrow transplantation for patients with acute leukemia. Buckner CD Transplant Proc; 1979 Mar; 11(1):215-8. PubMed ID: 377636 [No Abstract] [Full Text] [Related]
12. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640 [TBL] [Abstract][Full Text] [Related]
13. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen. Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation in hematologic malignancies. Thomas ED Hosp Pract (Off Ed); 1987 Feb; 22(2):77-91. PubMed ID: 3027113 [No Abstract] [Full Text] [Related]
15. Allogeneic bone marrow transplantation for acute leukemia in children. A short review. Masotti A; Baccarani M Haematologica; 1985; 70(6):536-44. PubMed ID: 3938434 [No Abstract] [Full Text] [Related]
16. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. Blume KG; Beutler E; Bross KJ; Chillar RK; Ellington OB; Fahey JL; Farbstein MJ; Forman SJ; Schmidt GM; Scott EP; Spruce WE; Turner MA; Wolf JL N Engl J Med; 1980 May; 302(19):1041-6. PubMed ID: 6245359 [TBL] [Abstract][Full Text] [Related]
17. Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients. Min CK; Eom KS; Lee S; Kim DW; Lee JW; Min WS; Kim CC Bone Marrow Transplant; 2001 May; 27(9):999-1005. PubMed ID: 11436112 [TBL] [Abstract][Full Text] [Related]
18. [Present status of donor leukocyte transfusion for leukemia. Relapse after allogeneic bone marrow transplantation in Japan]. Morishima Y; Kodera Y Rinsho Ketsueki; 1997 Jun; 38(6):476-8. PubMed ID: 9248321 [No Abstract] [Full Text] [Related]
19. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia. Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544 [TBL] [Abstract][Full Text] [Related]
20. Treatment of leukemia with partially matched related bone marrow transplantation. Munn RK; Henslee-Downey PJ; Romond EH; Marciniak EJ; Fleming DR; Messino MJ; Macdonald JS; Rayens MK; Harder EJ; Phillips GL; Thompson JS Bone Marrow Transplant; 1997 Mar; 19(5):421-7. PubMed ID: 9052906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]